Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study.

Udumyan, Ruzan; Botteri, Edoardo; Jerlstrom, Tomas; Montgomery, Scott; Smedby, Karin E; Fall, Katja

Udumyan, Ruzan; Botteri, Edoardo; Jerlstrom, Tomas; Montgomery, Scott; Smedby, Karin E; Fall, Katja.

Affiliation

Udumyan R; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.
Botteri E; Department of Research, Cancer Registry of Norway, Oslo, Norway.
Jerlstrom T; Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
Montgomery S; Department of Urology, School of Health and Medical Sciences, Örebro University, Örebro, Sweden.
Smedby KE; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.
Fall K; Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.

Acta Oncol ; 61(8): 922-930, 2022 Aug.

Article in En | MEDLINE | ID: mdl-35881046

Subject(s)

Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Adrenergic beta-Antagonists/therapeutic use; Carcinoma, Transitional Cell/drug therapy; Cohort Studies; Humans; Retrospective Studies; Sweden/epidemiology; Urinary Bladder Neoplasms/drug therapy

Key words

Adrenergic signaling; beta-blocker; cohort study; survival; urothelial bladder cancer

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Sweden

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google